Real-World Direct Comparison of the Effectiveness and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Medicare Beneficiaries With Atrial Fibrillation

2020/04/10 by Lanting Yang, Maria M. Brooks, Nancy W. Glynn +3 · 9 citations
Medicine · #Atrial Fibrillation Management and Outcomes #Cardiac Arrhythmias and Treatments #Blood Pressure and Hypertension Studies

paper · doi:10.1016/j.amjcard.2020.03.034

Cited by

• Non-vitamin K antagonist oral anticoagulants versus vitamin K antagonists in atrial fibrillation patients with previous stroke or intracranial hemorrhage: A systematic review and meta-analysis of observational studies. [europepmc]
• Use of oral anticoagulants among individuals with cancer and atrial fibrillation in the United States, 2010-2016. [europepmc]
• Effectiveness and Safety of Apixaban in over 3.9 Million People with Atrial Fibrillation: A Systematic Review and Meta-Analysis. [europepmc]
• Effectiveness and Safety of Non-Vitamin K Oral Anticoagulants versus Warfarin in Patients with Atrial Fibrillation and Previous Stroke: A Systematic Review and Meta-Analysis. [europepmc]
• COVID-19 pandemic and trends in clinical outcomes and medication use for patients with established atrial fibrillation: A nationwide analysis of claims data. [europepmc]
• Effectiveness and safety in non-valvular atrial fibrillation patients switching from warfarin to direct oral anticoagulants in US healthcare claims. [europepmc]
• COVID-19 Diagnosis, Oral Anticoagulation, and Stroke Risk in Patients with Atrial Fibrillation. [europepmc]
• Comparison of Safety and Effectiveness Between Direct Oral Anticoagulants and Vitamin K Antagonists in Dementia Patients with Atrial Fibrillation: A Systematic Review and Meta-Analysis. [europepmc]
• Enhanced Prediction of Atrial Fibrillation in Patients With Ischemic Stroke Through Electronic Medical Records and Text Mining: Algorithm Development and Validation. [europepmc]